Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma

Eosinophilic airway inflammation can predict the exacerbation of asthma, and we can improve the management of asthma by monitoring the eosinophilic airway inflammation. Although induced sputum and sputum eosinophil count is the gold standard test for diagnosing eosinophilic asthma, a more accessible and receptive method is needed for clinical practice. Type 2 innate lymphoid cells (ILC2) have recently been proposed to play a crucial role in eosinophilic inflammation and have been identified in peripheral blood from patients with asthma.

Source: Respiratory Medicine CME - October 5, 2015 Category: Respiratory Medicine Authors: Tian Liu, Jinxiang Wu, Jiping Zhao, Junfei Wang, Yuanyuan Zhang, Lin Liu, Liuzhao Cao, Yahui Liu, Liang Dong Source Type: research